Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial

  1. Dalbeth, N.
  2. Jones, G.
  3. Terkeltaub, R.
  4. Khanna, D.
  5. Kopicko, J.
  6. Bhakta, N.
  7. Adler, S.
  8. Fung, M.
  9. Storgard, C.
  10. Baumgartner, S.
  11. Perez-Ruiz, F.
Revue:
Arthritis and Rheumatology

ISSN: 2326-5205,  2326-5191

Année de publication: 2017

Volumen: 69

Número: 9

Pages: 1903-1913

Type: Article

DOI: 10.1002/ART.40159 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus